share_log

Insiders Selling Nasdaq, Bristol-Myers Squibb And This Consumer Defensive Stock

Insiders Selling Nasdaq, Bristol-Myers Squibb And This Consumer Defensive Stock

出售納斯達克、百時美施貴寶和這家消費者防禦性股票的內部人士
Benzinga Real-time News ·  2022/09/23 11:06

The Nasdaq Composite dropped by around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

週四,納斯達克綜合指數下跌約150點。與此同時,投資者關注的是一些值得注意的內幕交易。

When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

當內部人士出售股票時,這表明他們對公司前景的擔憂,或者他們認為股票定價過高。無論哪種方式,這都標誌着做空該股的機會。內幕交易不應被視為做出投資或交易決定的唯一指標。充其量,它可以讓拋售決定更有説服力。

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

以下是最近一些值得注意的內幕交易。欲瞭解更多信息,請查看Benzinga的內幕交易站臺。

Nu Skin Enterprises

如新企業

  • The Trade: Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D Lipman sold a total of 1,000 shares at an average price of $36.67. The insider received around $36.67 thousand from selling those shares.
  • What's Happening: The company, last month, posted downbeat quarterly earnings.
  • What Nu Skin Enterprises Does: Nu Skin Enterprises Inc is a health and beauty direct-selling company with a comprehensive product line: anti-aging skin products; peels, masks, and scrubs; moisturizers; body care; hair care; men's care; oral care; sun protection; and cosmetics.
  • 行業:如新企業股份有限公司(紐約證券交易所市場代碼:NUS)董事安德魯·D·利普曼共售出1,000股均價為36.67美元。這位內部人士從出售這些股票中獲得了約366.7萬美元。
  • 正在發生的事情:上個月,該公司公佈了悲觀的季度收益。
  • 如新企業的業務範圍:如新企業是一家健康美容直銷公司,擁有全面的產品線:抗衰老皮膚產品;去皮、面膜和磨砂;保濕產品;身體護理;頭髮護理;男士護理;口腔護理;防曬和化粧品。

Also check this: Darden Restaurants To Gain 7%? Here Are 5 Other Price Target Changes For Friday

還可以查一下:達頓餐廳的收益是7%?以下是週五的其他5個目標價變化

Bristol-Myers Squibb Company

百時美施貴寶公司

  • The Trade: Bristol-Myers Squibb Company (NYSE:BMY) Board Chair and CEO Giovanni Caforio sold a total of 25,000 shares at an average price of $69.71. The insider received around $1.74 million as a result of the transaction.
  • What's Happening: The European Commission approved Bristol Myers Squibb's fixed-dose combination of Opdualag (nivolumab and relatlimab) for melanoma patients aged 12 years and above.
  • What Bristol-Myers Squibb Does: Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders.
  • 行業: 百時美施貴寶公司(紐約證券交易所股票代碼:BMY)董事會主席兼首席執行官喬瓦尼·卡福裏奧總共出售了25,000股均價為69.71美元。這位內部人士通過這筆交易獲得了約174萬美元。
  • 正在發生的事情:歐盟委員會批准百時美施貴寶的固定劑量Opdualag(nivolumab和relatlimab)組合用於12歲及以上的黑色素瘤患者。
  • 百時美施貴寶的做法:百時美施貴寶發現、開發和營銷各種治療領域的藥物,如心血管、癌症和免疫疾病。

Have a look at our premarket coverage here .

在這裏看看我們的售前報道。

Nasdaq

納斯達克

  • The Trade: Nasdaq, Inc. (NASDAQ:NDAQ) Executive Vice President Jeremy Skule sold a total of 2,100 shares at an average price of $59.80. The insider received around $125.58 thousand from selling those shares.
  • What's Happening: In an apparent bid to tap into the growing lure of high-net-worth individuals into the crypto space, Nasdaq will offer custody services for Bitcoin and Ethereum to institutional investors.
  • What Nasdaq Does: Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%).
  • 行業: 納斯達克公司納斯達克(股票代碼:NDAQ)執行副總裁總裁傑裏米·斯庫勒共售出2,100股均價為59.80美元。這位內部人士從出售這些股票中獲得了約125.58萬美元。
  • 正在發生的事情:納斯達克將向機構投資者提供比特幣和以太的託管服務,這顯然是為了利用高淨值人士進入密碼領域日益增長的吸引力。
  • 納斯達克的用途:納斯達克成立於1971年,主要以股權交易聞名,但除了市場服務業務(約佔銷售額的35%)外,該公司還通過信息服務部門(約佔銷售額的30%)出售和分發市場數據,並向資產管理公司和投資者提供納斯達克品牌的指數。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論